Laboratory Research

Immunohistochemistry of Vitreous Cells from Patients with Posterior Uveitis

Medical Professionals

We analyzed vitreous specimens from 4 patients undergoing diagnostic and/or therapeutic pars plana vitrectomy, employing immunohistochemical staining of the vitreous cells with monoclonal antibodies directed against T and B cell subsets, anti-CD 25 (activation marker) molecule, and the adhesion molecule, VCAM-1. T cells were abundant in all 4 specimens, and in specimens from 2 of the patients who had retinal vasculitis, Interleukin 2 receptor was significantly expressed on the cells. VCAM-1 was expressed on the cells from all of the samples.

We conclude that these locally activated vitreal inflammatory cells play an important role in the pathogenesis of immunologically mediated posterior uveitis, and, further, believe that the finding of such cells additionally supports the idea that therapeutic vitrectomy in the care of patients with frequently recurrent, chronic posterior uveitis may exert much of its therapeutic benefit through the removal of such cells which reside on the vitreous fibrils and elaborate amplifying inflammatory cytokines.

Physician Education

Related Articles

A glossary of terms
Patient Education
Arash Maleki, MD and C. Stephen Foster MD, FACS, FACR
April 1, 2026
The ocular manifestations of acquired immunodeficiency syndrome (AIDS) revolve primarily around infectious and malignant diseases.
Physician Education
Prolonged inflammation of the ocular surface causes destruction of corneal stem cells that can result in corneal epithelial defect and/or sterile corneal ulcer.
Get involved

Join Us

DONATE
TODAY

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Participate in
RESEARCH

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Join Our
Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

About Contact